Internet Archive Scholar

In-hospital mortality among immunosuppressed patients with COVID-19: Analysis from a national cohort in Spain

Inés Suárez-García, Isabel Perales-Fraile, Andrés González-García, Arturo Muñoz-Blanco, Luis Manzano, Martín Fabregate, Jesús Díez-Manglano, Eva Fonseca Aizpuru, Francisco Arnalich Fernández, Alejandra García García, Ricardo Gómez-Huelgas, José-Manuel Ramos-Rincón (+2 others)
2021 PLoS ONE  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (542.5 kB)
https://web.archive.org/web/20210805232832/https://storage.googleapis.com/plos-corpus-prod/10.1371/journal.pone.0255524/1/pone.0255524.pdf?X-Goog-Algorithm=GOOG4-RSA-SHA256&X-Goog-Credential=wombat-sa%40plos-prod.iam.gserviceaccount.com%2F20210805%2Fauto%2Fstorage%2Fgoog4_request&X-Goog-Date=20210805T232832Z&X-Goog-Expires=86400&X-Goog-SignedHeaders=host&X-Goog-Signature=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

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL. The file type is application/pdf.

Whether immunosuppressed (IS) patients have a worse prognosis of COVID-19 compared to non-IS patients is not known. The aim of this study was to evaluate the clinical characteristics and outcome of IS patients hospitalized with COVID-19 compared to non-IS patients. Methods We designed a retrospective cohort study. We included all patients hospitalized with laboratory-confirmed COVID-19 from the SEMI-COVID-19 Registry, a large multicentre national cohort in Spain, from March 27th until June
more » ... 2020. We used multivariable logistic regression to assess the adjusted odds ratios (aOR) of in-hospital death among IS compared to non-IS patients. Results Among 13 206 included patients, 2 111 (16.0%) were IS. A total of 166 (1.3%) patients had solid organ (SO) transplant, 1081 (8.2%) had SO neoplasia, 332 (2.5%) had hematologic neoplasia, and 570 (4.3%), 183 (1.4%) and 394 (3.0%) were receiving systemic steroids, biological treatments, and immunosuppressors, respectively. Compared to non-IS patients, the aOR (95% CI) for in-hospital death was 1.60 (1.43–1.79) for all IS patients, 1.39 (1.18–1.63) for patients with SO cancer, 2.31 (1.76–3.03) for patients with haematological cancer and 3.12 (2.23–4.36) for patients with SO transplant. The aOR (95% CI) for death for patients who were receiving systemic steroids, biological treatments and immunosuppressors compared to non-IS patients were 2.16 (1.80–2.61), 1.97 (1.33–2.91) and 2.06 (1.64–2.60), respectively. IS patients had a higher odds than non-IS patients of in-hospital acute respiratory distress syndrome, heart failure, myocarditis, thromboembolic disease and multiorgan failure. Conclusions IS patients hospitalized with COVID-19 have a higher odds of in-hospital complications and death compared to non-IS patients.
doi:10.1371/journal.pone.0255524 fatcat:a5i3c52w55ernipwdlti66gt3y
DOAJ
Citation

Inés Suárez-García, Isabel Perales-Fraile, Andrés González-García, Arturo Muñoz-Blanco, Luis Manzano, Martín Fabregate, Jesús Díez-Manglano, Eva Fonseca Aizpuru, Francisco Arnalich Fernández, Alejandra García García, Ricardo Gómez-Huelgas, José-Manuel Ramos-Rincón, on behalf of SEMI-COVID-19 Network, Aleksandar R. Zivkovic. "In-hospital mortality among immunosuppressed patients with COVID-19: Analysis from a national cohort in Spain." PLoS ONE 16.8 (2021) e0255524